Deferasirox, dalfampridine, nilotinib
Ended Awarded
- Contract number
- VA69D12F2288
- Awardee
-
Novartis Pharmaceuticals Corporation UEI NG61ZA8TADW3
- Awarding agency
-
Veterans Integrated Service Network 12
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $33,505
Award facts
- Contract value 100% obligated
- $33,504.57 Current and potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Madison, WI 53705, USA
Award details come from SAM.gov/FPDS.
Quick answers
Who was awarded contract VA69D12F2288?
VA69D12F2288 was awarded to Novartis Pharmaceuticals Corporation by Veterans Integrated Service Network 12 (Veterans Health Administration) on July 30, 2012.
How much is contract VA69D12F2288 worth?
The government has obligated $33,505 on VA69D12F2288.
Is contract VA69D12F2288 an order under another contract?
Yes. VA69D12F2288 is a delivery order under V797P5879X, a federal supply schedule.
Was contract VA69D12F2288 competed?
The extent of competition for VA69D12F2288 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award